arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Nuvation Bio Inc.

NUVB

$6.60 ▲ +0.49 (+8.02%) at close

26 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Nuvation Bio Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.3M

Dividend Yield —

Revenue Growth 2598.7% ↗

Op. Margin 4.7% ↗

ROIC 1.1% ↗

FCF / Share $14.59

Trailing P/E 330.0x

Price / Book 7.2x

FCF Yield 221.1%

Debt / Equity 0.17

info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$83.23M

↑ +2598.7% —

Net Income Profit after all expenses

$5.40M

↑ +114.7% —

Operating Margin Operating profit as % of sales

4.7%

↑ +105.7% 0th

FCF / Share Free cash flow per share

$14.59

↑ +109.4% —

Long-Term Debt Long-term obligations

$47.33M

— +0.3% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability

Returns ↓

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Apr 23, 2020 10-K ↗
Revenue Growth YoY (%)	2598.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+32384%)	633.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+7813%)	1704.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+21208%)	236.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2860%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	N/M	—	-6.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	91.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-128.6% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	100.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-66.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-2000.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	30.0% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	22.2% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	25.0% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	43.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	25.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	26.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-259.9% Weak → Weak Stable Year-over-year change in net income	-259.9% Weak ↓ Weak Declining Year-over-year change in net income	-259.9% Weak ↓ Weak Declining Year-over-year change in net income	-258.6% Weak ↓ Weak Declining Year-over-year change in net income	31.9% Excellent → Excellent Stable Year-over-year change in net income	31.9% Excellent ↑ Excellent Improving Year-over-year change in net income	31.9% Excellent ↑ Excellent Improving Year-over-year change in net income	33.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-2.0% Weak ↓ Weak Declining Year-over-year change in net income	-2.0% Weak ↓ Weak Declining Year-over-year change in net income	-2.0% Weak ↓ Weak Declining Year-over-year change in net income	17.1% Good ↑ Good Improving Year-over-year change in net income	-4.4% Weak ↑ Weak Improving Year-over-year change in net income	-4.4% Weak ↑ Weak Improving Year-over-year change in net income	-4.4% Weak ↑ Weak Improving Year-over-year change in net income	-89.3% Weak ↑ Weak Improving Year-over-year change in net income	-133.3% Weak → Weak Stable Year-over-year change in net income	-133.3% Weak Weak Year-over-year change in net income	-133.3% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	N/M	—	—	—	-75.6% Weak Weak Year-over-year change in free cash flow	—	—	—	18.9% Good Good Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Apr 23, 2020 10-K ↗
Operating Margin (%) (%)	4.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-69%)	-81.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-642%)	-430.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2968%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—
Profit Margin (%) (%)	6.5% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-46%)	-87.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-828%)	-405.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3481%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	6.1% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	-71.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-403.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.94x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.06x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.80x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.17x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	-0.72x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	2.78x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	-1.00x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Apr 23, 2020 10-K ↗
Return on Invested Capital (%)	1.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-15.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-182.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-3.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-4.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-3.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.4% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-5.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-2.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-2.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-6.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	0.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-12.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-79.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-3.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-4.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-3.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-5.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-2.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-2.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-2.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-6.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	1.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-89%)	-12.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-180%)	-16.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-209%)	-14.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-195%)	-12.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-185%)	-10.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-171%)	-2.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-120%)	-5.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-138%)	-2.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-117%)	-2.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-115%)	-3.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-124%)	-3.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-123%)	-3.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-123%)	-3.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-121%)	-3.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-121%)	-3.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-120%)	-2.9% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-120%)	-3.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-122%)	-2.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-118%)	-2.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-117%)	-2.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-117%)	-6.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-141%)	-9.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-163%)	-8.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-157%)	-7.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-153%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Apr 23, 2020 10-K ↗
Debt to Equity (x)	0.17x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-72%)	0.17x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-71%)	0.16x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-73%)	0.14x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-77%)	0.01x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-98%)	0.01x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-98%)	0.02x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-97%)	0.05x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	—	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	—	—	-11.02x Weak Weak Operating income divided by interest expense Optimal: > 5x	-239.06x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-3563.52x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-72.27M	$-111.15M	$-46.19M	$-195.41M	$-42.29M	$-29.44M	$-21.61M	$-22.65M	$-34.51M	$-42.65M	$-24.39M	—	$-30.07M	$-101.10M	$-138.69M	$-102.32M	$-106.21M	$-132.42M	$-344.63M	$-449.53M	$-638.90M	$-29.75M	—	—	—	$0.00
Debt / EBITDA (x)	13.69x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.56x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.93x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.83x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.10x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.12x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.18x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.02x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Apr 23, 2020 10-K ↗
Revenue per Share (USD)	$239.62	—	$38.32	$14.18	$9.11	—	$2.66	$5.86	—	—	—	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$0.02	$-0.11	$-0.16	$-0.17	$-0.16	$0.00	$-0.15	$-1.89	$-0.07	$-0.07	$-0.09	$-0.09	$-0.10	$-0.09	$-0.12	$-0.16	—	$-0.12	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$14.59	—	$-154.47	$-141.39	$-125.89	—	—	—	$-71.68	—	—	$-79.90	$-88.37	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.92	$0.90	$0.96	$1.10	$1.24	$1.37	$1.50	$1.03	$2.71	$2.76	$2.79	$2.85K	$2.93	$3.00	$3.06	$3.18	$3.32	$3.42	$3.53	$3.62	$3.70	$1.44	—	—	—	—
Tangible Book Value per Share (USD)	$0.92	$0.90	$0.96	$1.10	$1.24	$1.37	$1.50	$1.03	$2.71	$2.76	$2.79	$2.85K	$2.93	$3.00	$3.06	$3.18	$3.32	$3.42	$3.53	$3.62	$3.70	$1.44	—	—	—	—
Basic Weighted Avg Shares (shares)	347,332	—	342,393	340,746	338,612	—	273,565	244,738	219,048	—	218,935	218,848	218,741	—	218,300	216,603	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Apr 23, 2020 10-K ↗
Working Capital (USD)	$512.01M	$489.29M	$509.40M	$556.85M	$422.80M	$468.01M	$505.95M	$536.08M	$592.29M	$602.46M	$609.21M	—	$640.01M	$654.16M	$667.38M	$692.99M	$726.60M	$755.15M	$783.30M	$802.99M	$820.88M	$214.13M	—	—	—	—
LT Debt (USD)	$47.33M	$47.21M	$47.09M	$46.97M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$319.56M	$305.72M	$325.88M	$372.91M	$419.46M	$463.79M	$502.71M	$257.19M	$594.04M	$605.12M	$611.59M	$624.63M	$641.07M	$655.08M	$667.93M	$693.08M	$723.56M	$746.00M	$769.37M	$788.93M	$806.34M	$215.08M	$91.85M	$102.88M	$110.16M	$0.00

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Apr 23, 2020 10-K ↗
Sales/Revenue/Turnover (USD)	$83.23M	$41.87M	$13.12M	$4.83M	$3.08M	$5.71M	$727.00K	$1.44M	—	$0.00	—	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$5.40M	$-36.59M	$-53.24M	$-53.24M	$-53.24M	$-49.45M	$-14.79M	$-14.79M	$-14.79M	$-13.79M	$-21.73M	$-21.73M	$-21.73M	$-20.84M	$-21.29M	$-21.29M	$-21.29M	$-25.13M	$-20.40M	$-20.40M	$-20.40M	$-13.28M	$-8.75M	$-8.75M	$-8.75M	—
Operating Cash Flow (USD)	$5.07M	$-29.73M	$-52.89M	$-48.18M	$-42.63M	$-46.30M	—	—	$-15.70M	$-15.03M	—	$-17.48M	$-19.33M	$-16.17M	—	—	$-24.93M	$-23.48M	—	—	$14.73M	$-12.94M	$-8.04M	$-24.27M	$8.72M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

Nuvation Bio Inc.

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare NUVB with peers